{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T09:01:55Z","timestamp":1792227715066,"version":"4.4.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hormones"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.14310\/horm.2002.1679","type":"journal-article","created":{"date-parts":[[2016,6,26]],"date-time":"2016-06-26T19:30:57Z","timestamp":1466969457000},"page":"277-282","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Delayed diagnosis of disorder of sex development (DSD) due to P450 oxidoreductase (POR) deficiency"],"prefix":"10.1007","volume":"15","author":[{"given":"Vasiliki","family":"Koika","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia K.","family":"Armeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neoklis A.","family":"Georgopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,5,30]]},"reference":[{"key":"15020277_CR1","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/ng1300","volume":"36","author":"CE Fluck","year":"2004","unstructured":"Fluck CE, Tajima T, Pandey AV, et al, 2004 Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome. Nat Genet 36: 228\u2013230.","journal-title":"Nat Genet"},{"key":"15020277_CR2","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1016\/S0140-6736(04)17344-3","volume":"364","author":"WL Miller","year":"2004","unstructured":"Miller WL, Huang N, Fluck CE, Pandey AV, 2004 P450 oxidoreductase deficiency. Lancet 364: 1663.","journal-title":"Lancet"},{"key":"15020277_CR3","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.pharmthera.2013.01.010","volume":"138","author":"AV Pandey","year":"2013","unstructured":"Pandey AV, Fluck CE, 2013 NADPH P450 oxidoreductase: structure, function, and pathology of diseases. Pharmacol Ther 138: 229\u2013254.","journal-title":"Pharmacol Ther"},{"key":"15020277_CR4","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3389\/fphar.2014.00103","volume":"5","author":"AV Pandey","year":"2014","unstructured":"Pandey AV, Sproll P, 2014 Pharmacogenomics of human P450 oxidoreductase. Front Pharmacol 5: 103.","journal-title":"Front Pharmacol"},{"key":"15020277_CR5","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1056\/NEJM198511073131903","volume":"313","author":"RE Peterson","year":"1985","unstructured":"Peterson RE, Imperato-McGinley J, Gautier T, Shackleton C, 1985 Male pseudohermaphroditism due to multiple defects in steroid-biosynthetic microsomal mixed-function oxidases. A new variant of congenital adrenal hyperplasia. N Engl J Med 313: 1182\u20131191.","journal-title":"N Engl J Med"},{"key":"15020277_CR6","doi-asserted-by":"publisher","first-page":"6536","DOI":"10.1074\/jbc.M111408200","volume":"277","author":"AL Shen","year":"2002","unstructured":"Shen AL, O\u2019Leary KA, Kasper CB, 2002 Association of multiple developmental defects and embryonic lethality with loss of microsomal NADPH-cytochrome P450 oxidoreductase. J Biol Chem 277: 6536\u20136541.","journal-title":"J Biol Chem"},{"key":"15020277_CR7","doi-asserted-by":"publisher","first-page":"6103","DOI":"10.1128\/MCB.23.17.6103-6116.2003","volume":"23","author":"DM Otto","year":"2003","unstructured":"Otto DM, Henderson CJ, Carrie D, et al, 2003 Identification of novel roles of the cytochrome p450 system in early embryogenesis: effects on vasculogenesis and retinoic Acid homeostasis. Mol Cell Biol 23: 6103\u20136116.","journal-title":"Mol Cell Biol"},{"key":"15020277_CR8","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1086\/429417","volume":"76","author":"N Huang","year":"2005","unstructured":"Huang N, Pandey AV, Agrawal V, et al, 2005 Diversity and function of mutations in p450 oxidoreductase in patients with Antley-Bixler syndrome and disordered steroidogenesis. Am J Hum Genet 76: 729\u2013749.","journal-title":"Am J Hum Genet"},{"key":"15020277_CR9","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1210\/me.2007-0066","volume":"21","author":"V Dhir","year":"2007","unstructured":"Dhir V, Ivison HE, Krone N, et al, 2007 Differential inhibition of CYP17A1 and CYP21A2 activities by the P450 oxidoreductase mutant A287P. Mol Endocrinol 21: 1958\u20131968.","journal-title":"Mol Endocrinol"},{"key":"15020277_CR10","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1210\/me.2007-0245","volume":"21","author":"AV Pandey","year":"2007","unstructured":"Pandey AV, Kempna P, Hofer G, Mullis PE, Fluck CE, 2007 Modulation of human CYP19A1 activity by mutant NADPH P450 oxidoreductase. Mol Endocrinol 21: 2579\u20132595.","journal-title":"Mol Endocrinol"},{"key":"15020277_CR11","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.bbrc.2011.08.001","volume":"412","author":"CE Fluck","year":"2011","unstructured":"Fluck CE, Mallet D, Hofer G, et al, 2011 Deletion of P399_E401 in NADPH cytochrome P450 oxidoreductase results in partial mixed oxidase deficiency. Biochem Biophys Res Commun 412: 572\u2013577.","journal-title":"Biochem Biophys Res Commun"},{"key":"15020277_CR12","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1210\/jc.2008-2816","volume":"94","author":"M Fukami","year":"2009","unstructured":"Fukami M, Nishimura G, Homma K, et al, 2009 Cytochrome P450 oxidoreductase deficiency: identification and characterization of biallelic mutations and genotype-phenotype correlations in 35 Japanese patients. J Clin Endocrinol Metab 94: 1723\u20131731.","journal-title":"J Clin Endocrinol Metab"},{"key":"15020277_CR13","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1159\/000114857","volume":"69","author":"RR Scott","year":"2008","unstructured":"Scott RR, Miller WL, 2008 Genetic and clinical features of p450 oxidoreductase deficiency. Horm Res 69: 266\u2013275.","journal-title":"Horm Res"},{"key":"15020277_CR14","doi-asserted-by":"publisher","first-page":"4992","DOI":"10.1210\/jc.2009-1460","volume":"94","author":"T Sahakitrungruang","year":"2009","unstructured":"Sahakitrungruang T, Huang N, Tee MK, et al, 2009 Clinical, genetic, and enzymatic characterization of P450 oxidoreductase deficiency in four patients. J Clin Endocrinol Metab 94: 4992\u20135000.","journal-title":"J Clin Endocrinol Metab"},{"key":"15020277_CR15","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.mce.2010.10.022","volume":"336","author":"WL Miller","year":"2011","unstructured":"Miller WL, Agrawal V, Sandee D, et al, 2011 Consequences of POR mutations and polymorphisms. Mol Cell Endocrinol 336: 174\u2013179.","journal-title":"Mol Cell Endocrinol"},{"key":"15020277_CR16","doi-asserted-by":"publisher","first-page":"E257","DOI":"10.1210\/jc.2011-0640","volume":"97","author":"NI Krone","year":"2012","unstructured":"Krone NI, Reisch N, Idkowiak J, et al, 2012 Genotype-phenotype analysis in congenital adrenal hyperplasia due to P450 oxidoreductase deficiency. J Clin Endocrinol Metab 97: E257\u2013267.","journal-title":"J Clin Endocrinol Metab"},{"key":"15020277_CR17","doi-asserted-by":"publisher","first-page":"3619","DOI":"10.1210\/jc.2005-2283","volume":"91","author":"J Yang","year":"2006","unstructured":"Yang J, Cui B, Sun S, et al, 2006 Phenotype-genotype correlation in eight Chinese 17alpha-hydroxylase\/17,20 lyase-deficiency patients with five novel mutations of CYP17A1 gene. J Clin Endocrinol Metab 91: 3619\u20133625.","journal-title":"J Clin Endocrinol Metab"},{"key":"15020277_CR18","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1016\/S0140-6736(04)16503-3","volume":"363","author":"W Arlt","year":"2004","unstructured":"Arlt W, Walker EA, Draper N, et al, 2004 Congenital adrenal hyperplasia caused by mutant P450 oxidoreductase and human androgen synthesis: analytical study. Lancet 363: 2128\u20132135.","journal-title":"Lancet"},{"key":"15020277_CR19","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nmeth.2890","volume":"11","author":"JM Schwarz","year":"2014","unstructured":"Schwarz JM, Cooper DN, Schuelke M, Seelow D, 2014 MutationTaster2: mutation prediction for the deep-sequencing age. Nat Methods 11: 361\u2013362.","journal-title":"Nat Methods"},{"key":"15020277_CR20","doi-asserted-by":"publisher","first-page":"3812","DOI":"10.1093\/nar\/gkg509","volume":"31","author":"PC Ng","year":"2003","unstructured":"Ng PC, Henikoff S, 2003 SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Res 31: 3812\u20133814.","journal-title":"Nucleic Acids Res"},{"key":"15020277_CR21","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/humu.21642","volume":"33","author":"V Acharya","year":"2012","unstructured":"Acharya V, Nagarajaram HA, 2012 Hansa: an automated method for discriminating disease and neutral human nsSNPs. Hum Mutat 33: 332\u2013337.","journal-title":"Hum Mutat"},{"key":"15020277_CR22","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/humu.22250","volume":"34","author":"V Acharya","year":"2013","unstructured":"Acharya V, Nagarajaram HA, 2013 Response to: Statistical analysis of missense mutation classifiers. Hum Mutat 34: 407.","journal-title":"Hum Mutat"},{"key":"15020277_CR23","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1210\/jc.2004-0810","volume":"90","author":"M Fukami","year":"2005","unstructured":"Fukami M, Horikawa R, Nagai T, et al, 2005 Cytochrome P450 oxidoreductase gene mutations and Antley-Bixler syndrome with abnormal genitalia and\/or impaired steroidogenesis: molecular and clinical studies in 10 patients. J Clin Endocrinol Metab 90: 414\u2013426.","journal-title":"J Clin Endocrinol Metab"},{"key":"15020277_CR24","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1042\/BST0341186","volume":"34","author":"AV Pandey","year":"2006","unstructured":"Pandey AV, 2006 Biochemical analysis of mutations in P450 oxidoreductase. Biochem Soc Trans 34: 1186\u20131191.","journal-title":"Biochem Soc Trans"},{"key":"15020277_CR25","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.tem.2004.07.005","volume":"15","author":"WL Miller","year":"2004","unstructured":"Miller WL, 2004 P450 oxidoreductase deficiency: a new disorder of steroidogenesis with multiple clinical manifestations. Trends Endocrinol Metab 15: 311\u2013315.","journal-title":"Trends Endocrinol Metab"},{"key":"15020277_CR26","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1196\/annals.1336.012","volume":"1061","author":"WL Miller","year":"2005","unstructured":"Miller WL, Huang N, Pandey AV, Fluck CE, Agrawal V, 2005 P450 oxidoreductase deficiency: a new disorder of steroidogenesis. Ann N Y Acad Sci 1061: 100\u2013108.","journal-title":"Ann N Y Acad Sci"},{"key":"15020277_CR27","doi-asserted-by":"publisher","first-page":"3584","DOI":"10.1210\/jc.2008-0051","volume":"93","author":"E Hershkovitz","year":"2008","unstructured":"Hershkovitz E, Parvari R, Wudy SA, et al, 2008 Homozygous mutation G539R in the gene for P450 oxidoreductase in a family previously diagnosed as having 17,20-lyase deficiency. J Clin Endocrinol Metab 93: 3584\u20133588.","journal-title":"J Clin Endocrinol Metab"},{"key":"15020277_CR28","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1073\/pnas.0711621105","volume":"105","author":"N Huang","year":"2008","unstructured":"Huang N, Agrawal V, Giacomini KM, Miller WL, 2008 Genetics of P450 oxidoreductase: sequence variation in 842 individuals of four ethnicities and activities of 15 missense mutations. Proc Natl Acad Sci U S A 105: 1733\u20131738.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"15020277_CR29","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1210\/jc.2008-0304","volume":"93","author":"LG Gomes","year":"2008","unstructured":"Gomes LG, Huang N, Agrawal V, Mendonca BB, Bachega TA, Miller WL, 2008 The common P450 oxidoreductase variant A503V is not a modifier gene for 21-hydroxylase deficiency. J Clin Endocrinol Metab 93: 2913\u20132916.","journal-title":"J Clin Endocrinol Metab"},{"key":"15020277_CR30","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.mce.2008.09.017","volume":"300","author":"WL Miller","year":"2009","unstructured":"Miller WL, Huang N, Agrawal V, Giacomini KM, 2009 Genetic variation in human P450 oxidoreductase. Mol Cell Endocrinol 300: 180\u2013184.","journal-title":"Mol Cell Endocrinol"}],"container-title":["Hormones"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.14310\/horm.2002.1679.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.14310\/horm.2002.1679\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.14310\/horm.2002.1679.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T15:39:35Z","timestamp":1739115575000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.14310\/horm.2002.1679"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["15020277"],"URL":"https:\/\/doi.org\/10.14310\/horm.2002.1679","relation":{},"ISSN":["1109-3099","2520-8721"],"issn-type":[{"value":"1109-3099","type":"print"},{"value":"2520-8721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"29 September 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}